Michael B. Jebsen
2012
In 2012, Michael B. Jebsen earned a total compensation of $426.5K as President, Interim Chief Executive and Chief Financial Officer at Tenax Therapeutics, a 28% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $105,000 |
|---|---|
| Salary | $295,000 |
| Stock Awards | $16,856 |
| Other | $9,600 |
| Total | $426,456 |
Jebsen received $295K in salary, accounting for 69% of the total pay in 2012.
Jebsen also received $105K in non-equity incentive plan, $16.9K in stock awards and $9.6K in other compensation.
Rankings
In 2012, Michael B. Jebsen's compensation ranked 9,237th out of 11,487 executives tracked by ExecPay. In other words, Jebsen earned more than 19.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,237 out of 11,487 | 20th |
Division Manufacturing | 3,402 out of 4,253 | 20th |
Major group Chemicals And Allied Products | 929 out of 1,198 | 23rd |
Industry group Drugs | 692 out of 920 | 25th |
Industry Pharmaceutical Preparations | 534 out of 700 | 24th |
Source: SEC filing on August 1, 2012.
Jebsen's colleagues
We found two more compensation records of executives who worked with Michael B. Jebsen at Tenax Therapeutics in 2012.